Novel Coronavirus (COVID-2019) update: Please refer to the Centers for Disease Control and Prevention (CDC) website, www.cdc.gov/coronavirus
Joost J. Oppenheim

Joost J. Oppenheim

NIH/NCI, MD, USA

Title: Oncolytic Reagents may also Enhance Anti-Tumor Immunity by Inducing MyD88-dependent Maturation of Dendritic Cells

Joost J. Oppenheim

Jerry W. Shay

UT Southwestern Medical Center, Dallas,Texas

Title: Telomere Stress Potentiates STING-Dependent Anti-Tumor Immunity

Guido Kroemer

Guido Kroemer

Gustave Roussy Comprehensive Cancer Center, INSERM, France

Title: Overcoming a frequent inborn immune defect in breast cancer therapy

Lauren V. Wood

Lauren V. Wood

Chief Medical Officer, PDS Biotechnology, NJ

Title: Versamune (R-D0TAP): a Transformative Cationic Lipid Nanoparticle Technology Associated with Type I Interferon Specific Activation and Generation of Antibody, CD8 and CD4 T Cell Responses to Recombinant Proteins and Peptide Tumor Antigens

Wayne Godfrey

Wayne Godfrey

Vice President of Clinical Development at IGM Bioscience

Title: Novel Approach to Engineering Antibody Based Immunotherapy

Scott K. Durum

Scott K. Durum

NCI/CCR, NIH
MD, USA

Title: TBA

Eduardo Davila

Eduardo Davila

University of Colorado CU Comprehensive Cancer Center, CO

Title: Novel Gene Platforms to Maintain the Persistence and Antitumor Activity of TIL-, CAR-, and DC-Based Therapies

Shannon Lauberth

William Hearl

Ph.D. CEO, Immunomic Therapeutics, MD

Title: UNITE Platform, A Direct Antigen Presentation Approach in Oncology

Brian Francica

Brian Francica

Tempest Therapeutics, CA

Title: Dual Antagonism of Prostaglandin Receptors EP2 and EP4 by TPST-1495 Suppresses Tumor Growth and Stimulates Antitumor Immunity

Jing H. Wang

Jing H. Wang

University of Colorado Anschutz Medical Campus, CO

Title: MHC Class-I Independent Activation of Virtual- Memory CD8 T Cells Induced by Chemotherapeutic Agent-Treated Cancer Cells

Jing H. Wang

Pooja Jain

Drexel University College of Medicine, Philadelphia, PA

Title: The MAPK/ERK-regulated MEF-2 isoforms as potential new target(s) for HTLV-1 induced Adult T-cell leukemia/lymphoma (ATLL)

Jing H. Wang

Jason D. Marshall

Leidos Biomedical Research, Inc., NCI Campus at Frederick, MD

Title: Performance Optimization of a Novel HPV VLP Vaccine in Mice with Novel Adjuvants

Joseph Markowitz

Joseph Markowitz

Moffit Cancer Center, FL

Title: Duality of NO in Melanoma

Jean Gariepy

Jean Gariepy

Sunnybrook Research Institute, Toronto, Canada

Title: Development of high-valency protein-based agonists as immunomodulators

Yan Leyfmann

Yan Leyfmann

Penn State College of Medicine, PA

Title: Finetune Your CARs: Building the Next Generation of Anti-Cancer Therapies

Jessica E. Thaxton

Jessica E. Thaxton

Medical University of South Carolina, SC

Title: Metabolic Requirements for T Cell Protein Translation in Tumors

Theresa L. Whiteside

Theresa L. Whiteside

University of Pittsburgh School of Medicine and UPMC Hillman Cancer Center, PA

Title: Tumor-Derived Exosomes and Their Role in Cancer Progression

Subscribe and get our news and updates.